Skip to main content
Year archive

Galapagos NV — 2022 filings

All 167 regulatory filings released by Galapagos NV (GLPG) in 2022, sourced directly from the official regulator.

167 Filings
2022 Period
2022 filings (167)
Filing Released Lang
GALAPAGOS GENOMICS NV TR-1BE-ENG FMR TD2022-12-20 - Final (Part I)_Redacted.pdf
Major Shareholding Notification
2022-12-23 English
Galapagos receives transparency notification from FMR LLC.pdf
Major Shareholding Notification
2022-12-23 English
Galapagos ontvangt transparantieverklaring van FMR LLC.pdf
Major Shareholding Notification
2022-12-23 Dutch
6-K Filing
Foreign Filer Report
2022-12-23 English
Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a CD19 CAR-T candidate manufactured at point-of-care
Earnings Release Q4 2022
2022-12-13 Dutch
Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a CD19 CAR-T candidate manufactured at point-of-care
Earnings Release Q4 2022
2022-12-13 English
6-K Filing
Foreign Filer Report
2022-12-13 English
S-8 Filing
Registration Form
2022-12-12 English
6-K Filing
Foreign Filer Report
2022-11-14 English
Galapagos announces CHMP adoption of PRAC’s recommendation for Jyseleca® following extensive safety review of all JAK inhibitors
Legal Proceedings Report
2022-11-11 Dutch
Galapagos announces CHMP adoption of PRAC’s recommendation for Jyseleca® following extensive safety review of all JAK inhibitors
Regulatory Filings
2022-11-11 English
Galapagos to present encouraging initial data from FILOSOPHY real-world arthritis study at ACR Convergence 2022
Regulatory Filings
2022-11-09 English
Galapagos to present encouraging initial data from FILOSOPHY real-world arthritis study at ACR Convergence 2022
Regulatory Filings
2022-11-09 English
6-K Filing
Foreign Filer Report
2022-11-09 English
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
Investor Presentation
2022-11-07 English
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
Investor Presentation
2022-11-07 Dutch
6-K Filing
Foreign Filer Report
2022-11-07 English
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
Interim / Quarterly Report 9M 2022
2022-11-04 English
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
Interim / Quarterly Report 9M 2022
2022-11-04 English
6-K Filing
Foreign Filer Report
2022-11-04 English
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results.pdf
Earnings Release 9M 2022
2022-11-03 English
Galapagos kondigt strategie aan om innovatie te versnellen en rapporteert sterke resultaten in derde kwartaal 2022.pdf
Interim / Quarterly Report 9M 2022
2022-11-03 Dutch
03-11-2022-nxr-galapagos-ir322-webpdf-en-16-38-13.pdf
Interim / Quarterly Report 9M 2022
2022-11-03 English
03-11-2022-nxr-galapagos-ir322-webpdf-nl-16-38-15.pdf
Interim / Quarterly Report 9M 2022
2022-11-03 Dutch
Galapagos to host its R&D Update 2022 in New York on 4 November 2022
Report Publication Announcement
2022-10-17 English
Galapagos to host its R&D Update 2022 in New York on 4 November 2022
Report Publication Announcement
2022-10-17 Dutch
6-K Filing
Foreign Filer Report
2022-10-17 English
Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress
Regulatory Filings
2022-10-07 English
Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress
Regulatory Filings
2022-10-07 Dutch
6-K Filing
Foreign Filer Report
2022-10-06 English
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
Regulatory Filings
2022-10-04 Dutch
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
Regulatory Filings
2022-10-04 English
6-K Filing
Foreign Filer Report
2022-10-04 English
Galapagos increases share capital through subscription right exercises
Capital/Financing Update
2022-09-28 Dutch
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2022-09-28 English
Galapagos increases share capital through subscription right exercises.pdf
Share Issue/Capital Change
2022-09-27 English
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten.pdf
Capital/Financing Update
2022-09-27 Dutch
6-K Filing
Foreign Filer Report
2022-09-27 English
Galapagos receives transparency notification from FMR LLC
Major Shareholding Notification
2022-08-30 English
Galapagos receives transparency notification from FMR LLC
Major Shareholding Notification
2022-08-30 English
6-K Filing
Foreign Filer Report
2022-08-30 English
GALAPAGOS GENOMICS NV TR-1BE-ENG FMR TD2022-08-23 - Final (Part I)_Redacted.pdf
Major Shareholding Notification
2022-08-29 English
TN FMR_Aug25 ENG.pdf
Major Shareholding Notification
2022-08-29 English
TN FMR_Aug25 NL.pdf
Major Shareholding Notification
2022-08-29 Dutch
Galapagos to present at upcoming investor conferences
Report Publication Announcement
2022-08-25 English
Galapagos to present at upcoming investor conferences
Investor Presentation
2022-08-25 English
6-K Filing
Foreign Filer Report
2022-08-24 English
Galapagos receives transparency notification from FMR LLC
Major Shareholding Notification
2022-08-19 English
Galapagos receives transparency notification from FMR LLC
Major Shareholding Notification
2022-08-19 Dutch
6-K Filing
Foreign Filer Report
2022-08-19 English
GALAPAGOS GENOMICS NV TR-1BE-ENG FMR TD2022-08-09 - Final (Part I)_Redacted.pdf
Declaration of Voting Results & Voting Rights Announcements
2022-08-18 English
TN FMR_Aug2 ENG_f.pdf
Major Shareholding Notification
2022-08-18 English
TN FMR_Aug2 NL_f.pdf
Major Shareholding Notification
2022-08-18 Dutch
Galapagos receives transparency notification from FMR LLC
Major Shareholding Notification
2022-08-09 English
Galapagos receives transparency notification from FMR LLC
Declaration of Voting Results & Voting Rights Announcements
2022-08-09 English
6-K Filing
Foreign Filer Report
2022-08-09 English
GALAPAGOS GENOMICS NV TR-1BE-ENG FMR TD2022-07-29 - Final (Part I)_Redacted.pdf
Major Shareholding Notification
2022-08-08 English
Galapagos receives transparency notification from FMR LLC .pdf
Major Shareholding Notification
2022-08-08 English
Galapagos ontvangt transparantieverklaring van FMR LLC .pdf
Major Shareholding Notification
2022-08-08 Dutch
6-K Filing
Foreign Filer Report
2022-08-08 English
First key steps in pipeline rebuild and strong commercial progress in H1 2022
Interim / Quarterly Report H1 2022
2022-08-05 English
First key steps in pipeline rebuild and strong commercial progress in H1 2022
Earnings Release H1 2022
2022-08-05 Dutch
First key steps in pipeline rebuild and strong commercial progress in H1 2022.pdf
Interim / Quarterly Report H1 2022
2022-08-04 English
Eerste belangrijke stappen in heropbouw van pijplijn en sterke commerciële vooruitgang in H1 2022.pdf
Interim / Quarterly Report H1 2022
2022-08-04 Dutch
nxr-glpg-h122-en-FINAL-220804-1830.pdf
Interim / Quarterly Report H1 2022
2022-08-04 English
nxr-glpg-h122-nl-FINAL-220804-1830.pdf
Interim / Quarterly Report H1 2022
2022-08-04 Dutch
6-K Filing
Foreign Filer Report
2022-06-23 English
6-K Filing
Foreign Filer Report
2022-06-23 English
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
M&A Activity
2022-06-22 English
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
M&A Activity
2022-06-21 English
Galapagos neemt CellPoint en AboundBio over om toegang tot celtherapieën van de volgende generatie te versnellen
M&A Activity
2022-06-21 Dutch
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2022-06-21 English
Galapagos increases share capital through subscription right exercises.pdf
Share Issue/Capital Change
2022-06-20 English
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten.pdf
Share Issue/Capital Change
2022-06-20 Dutch
Galapagos ontvangt transparantieverklaring van FMR LLC
Major Shareholding Notification
2022-06-02 English
Galapagos ontvangt transparantieverklaring van FMR LLC
Major Shareholding Notification
2022-06-02 Dutch
6-K Filing
Foreign Filer Report
2022-06-02 English
GALAPAGOS GENOMICS NV TR-1BE-ENG FMR TD2022-05-27 - Final (Part I) Signature_Redacted.pdf
Declaration of Voting Results & Voting Rights Announcements
2022-06-01 English
Galapagos receives transparency notification from FMR LLC .pdf
Major Shareholding Notification
2022-06-01 English
Galapagos ontvangt transparantieverklaring van FMR LLC.pdf
Major Shareholding Notification
2022-06-01 Dutch
6-K Filing
Foreign Filer Report
2022-05-31 English
Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress
Regulatory Filings
2022-05-26 English
Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress
Regulatory Filings
2022-05-26 English
EGM & AGM minutes (ENG)(511592.1) (1)_2022.pdf
AGM Information
2022-05-11 English
EGM & AGM minutes (NL)(511591.1)_2022.pdf
AGM Information
2022-05-11 Dutch
6-K Filing
Foreign Filer Report
2022-05-11 English
Galapagos creates new subscription right plans
Capital/Financing Update
2022-05-09 Dutch
6-K Filing
Foreign Filer Report
2022-05-09 English
Galapagos creates new subscription right plans.pdf
Remuneration Information
2022-05-06 English
Galapagos creëert nieuwe inschrijvingsrechtenplannen.pdf
Share Issue/Capital Change
2022-05-06 Dutch
Subscription Right Plan 2022 BE_ROW_RMV_Board Report_7_180-7_191_E_Final - including Annexes.docx(510887.1).pdf
Share Issue/Capital Change
2022-05-06 English
Subscription Right Plan 2022 (B)_RvB Report_7_180-7_191_D_Final including Annexes.docx(510886.1).pdf
Capital/Financing Update
2022-05-06 Dutch
6-K Filing
Foreign Filer Report
2022-05-06 English
Galapagos demonstrates regulatory and commercial progress in Q1 2022.pdf
Earnings Release Q1 2022
2022-05-05 English
Galapagos toont regelgevende en commerciële voortgang bij eerste kwartaalresultaten 2022.pdf
Earnings Release Q1 2022
2022-05-05 Dutch
nxr_glpg_q122_en_FINAL-03_220505-1745.pdf
Interim / Quarterly Report Q1 2022
2022-05-05 English
nxr_glpg_q122_nl_FINAL-03_220505-1900.pdf
Interim / Quarterly Report Q1 2022
2022-05-05 Dutch
Galapagos creates new subscription right plans (1).pdf
Remuneration Information
2022-05-05 English
Galapagos creëert nieuwe inschrijvingsrechtenplannen (1).pdf
Share Issue/Capital Change
2022-05-05 Dutch
Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board
Board/Management Information
2022-05-05 English
Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board
Regulatory Filings
2022-05-05 English
6-K Filing
Foreign Filer Report
2022-04-28 English
6-K Filing
Foreign Filer Report
2022-04-27 English
6-K Filing
Foreign Filer Report
2022-04-11 English
nxr_galapagos_AR21_03-24_1630_EN_FINAL-DRAFT-03.pdf
Annual Report FY 2021
2022-03-29 English
nxr_galapagos_AR21_03-22_2140_NL_FINAL.pdf
Annual Report FY 2021
2022-03-29 Dutch
699400FG6E2AD50YHF38-2021-12-31-nl.xhtml
Annual Report FY 2021
2022-03-29 English
699400FG6E2AD50YHF38-2021-12-31-nl (3) (2).zip
Annual Report (ESEF) FY 2021
2022-03-29 English
Jyseleca® approved in Japan for ulcerative colitis
Regulatory Filings
2022-03-28 Dutch
Jyseleca® approved in Japan for ulcerative colitis
Regulatory Filings
2022-03-28 English
6-K Filing
Foreign Filer Report
2022-03-28 English
Correction: Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings
Report Publication Announcement
2022-03-25 English
Correction: Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings
Report Publication Announcement FY 2021
2022-03-25 English
6-K Filing
Foreign Filer Report
2022-03-25 English
Binder1.pdf
AGM Information
2022-03-24 Dutch
nxr_galapagos_AR21_03-24_1400_CSR_EN.pdf
Environmental & Social Information
2022-03-24 English
nxr_galapagos_AR21_03-24_1400_CSR_NL.pdf
Environmental & Social Information
2022-03-24 Dutch
Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings.pdf
AGM Information
2022-03-24 English
Galapagos publiceert 2021 jaarverslag en kondigt buitengewone en jaarlijkse aandeelhoudersvergaderingen aan.pdf
Report Publication Announcement FY 2021
2022-03-24 Dutch
20-F Filing
Annual Report FY 2021
2022-03-24 English
6-K Filing
Foreign Filer Report
2022-03-24 English
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2022-03-21 Dutch
Galapagos increases share capital through subscription right exercises
Declaration of Voting Results & Voting Rights Announcements
2022-03-21 English
Galapagos increases share capital through subscription right exercises.pdf
Declaration of Voting Results & Voting Rights Announcements
2022-03-18 English
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten.pdf
Share Issue/Capital Change
2022-03-18 Dutch
Galapagos 2021 results set stage for future growth
Earnings Release FY 2021
2022-02-25 English
Galapagos 2021 results set stage for future growth
Annual Report FY 2021
2022-02-25 English
Resultaten Galapagos 2021 zetten de toon voor toekomstige groei
Interim / Quarterly Report FY 2021
2022-02-25 Dutch
Resultaten Galapagos 2021 zetten de toon voor toekomstige groei
Annual Report FY 2021
2022-02-25 Dutch
fy 21_financial_tables_EN final.pdf
Annual Report FY 2021
2022-02-24 English
fy21_financial_tables_nl final.pdf
Interim / Quarterly Report FY 2021
2022-02-24 Dutch
Galapagos 2021 results set stage for future growth .pdf
Earnings Release FY 2021
2022-02-24 English
Resultaten Galapagos 2021 zetten de toon voor toekomstige groei.pdf
Annual Report FY 2021
2022-02-24 Dutch
6-K Filing
Foreign Filer Report
2022-02-24 English
Sustainability report 2022.pdf
Environmental & Social Information
2022-02-23 English
Duurzaamheidsverslag 2022.pdf
Environmental & Social Information
2022-02-23 Dutch
6-K Filing
Foreign Filer Report
2022-02-07 English
6-K Filing
Foreign Filer Report
2022-02-07 English
Galapagos receives transparency notification from EcoR1 Capital
Major Shareholding Notification
2022-02-04 English
Galapagos receives transparency notification from EcoR1 Capital
Major Shareholding Notification
2022-02-04 English
EcoR1 TN_f.pdf
Major Shareholding Notification
2022-02-03 English
Galapagos receives transparency notification from EcoR1 Capital .pdf
Major Shareholding Notification
2022-02-03 English
Galapagos ontvangt transparantieverklaring van EcoR1 Capital .pdf
Major Shareholding Notification
2022-02-03 Dutch
Galapagos provides further insights into the treatment of ulcerative colitis at the European Crohn’s and Colitis Organization (ECCO) annual congress
Regulatory Filings
2022-02-03 Dutch
Galapagos provides further insights into the treatment of ulcerative colitis at the European Crohn’s and Colitis Organization (ECCO) annual congress
Regulatory Filings
2022-02-03 English
SC 13G Filing
Major Shareholding Notification
2022-02-03 English
Galapagos creates new subscription right plan
Capital/Financing Update
2022-01-27 Dutch
Galapagos creates new subscription right plan
Remuneration Information
2022-01-27 English
Galapagos appoints Paul Stoffels as Chief Executive Officer
Board/Management Information
2022-01-27 Dutch
Galapagos appoints Paul Stoffels as Chief Executive Officer
Board/Management Information
2022-01-27 English
6-K Filing
Foreign Filer Report
2022-01-27 English
Galapagos creates new subscription right plan.pdf
Capital/Financing Update
2022-01-26 English
Galapagos creëert nieuw inschrijvingsrechtenplan.pdf
Capital/Financing Update
2022-01-26 Dutch
Galapagos appoints Paul Stoffels as Chief Executive Officer
Board/Management Information
2022-01-26 English
Galapagos benoemt Paul Stoffels tot Chief Executive Officer
Board/Management Information
2022-01-26 Dutch
6-K Filing
Foreign Filer Report
2022-01-26 English
JYSELECA®? (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN GREAT BRITAIN
Regulatory Filings
2022-01-19 English
JYSELECA®? (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN GREAT BRITAIN
Regulatory Filings
2022-01-19 English
6-K Filing
Foreign Filer Report
2022-01-19 English
Galapagos creates new subscription right plan
Remuneration Information
2022-01-14 English
Galapagos creates new subscription right plan
Share Issue/Capital Change
2022-01-14 English
Galapagos creates new subscription right plan.pdf
Share Issue/Capital Change
2022-01-13 English
Galapagos creëert nieuw inschrijvingsrechtenplan.pdf
Share Issue/Capital Change
2022-01-13 Dutch
6-K Filing
Foreign Filer Report
2022-01-13 English
6-K Filing
Foreign Filer Report
2022-01-10 English
Galapagos to present at 40th Annual J.P. Morgan Healthcare Conference
Report Publication Announcement
2022-01-06 English
Galapagos to present at 40th Annual J.P. Morgan Healthcare Conference
Investor Presentation
2022-01-06 English